Search results
Results from the WOW.Com Content Network
The Women's Health Initiative trials were conducted between 1991 and 2006 and were the first large, double-blind, placebo-controlled clinical trials of HRT in healthy women. [104] Their results were both positive and negative, suggesting that during the time of hormone therapy itself, there are increases in invasive breast cancer, stroke and ...
There’s no concrete answer, although one study found that women experience decreased sex drive between ages 55 and 64; another study found that as many as 40 percent of women over 60 have low ...
From an evolutionary perspective, increases in estrogens during fertile periods in females may direct sexual motivation toward males with preferential genes (the good genes hypothesis). Following natural or surgically induced menopause, many women experience declines in sexual motivation. [11]
HSDD in transgender women is largely caused by a lack of testosterone especially after the gonads are removed during bottom surgery, as androgens are produced in smaller concentrations lower than ovulating women. Progesterone has shown to alleviate some symptoms of HSDD in transgender women, as well as other hormone treatments. [8] [9]
What to expect during perimenopause, including lesser-known symptoms and how long this phase lasts. Many women are blindsided by perimenopause. 5 facts everyone should know about this time of life ...
Low libido is incredibly common in perimenopause and menopause. Treatments include vaginal estrogen, hormone replacement therapy, testosterone, CBT. 'I have zero desire': Low libido is common in ...
In transgender women, estradiol valerate given by intramuscular injection is usually used at a dosage of 5 to 20 mg, but up to 30 to 40 mg, once every 2 weeks. [30] [31] [29] Estradiol valerate has also been used at a dose of 10 to 40 mg by intramuscular injection to limit bleeding in women with hemorrhage due to dysfunctional uterine bleeding.
For premium support please call: 800-290-4726 more ways to reach us